GROWTH AND DIFFERENTIATION FACTORS FOR B-CELLS AND T-CELLS

被引:5
作者
HANSSON, M
机构
[1] Department of Immunology, Karolinska Institutet, Stockholm
关键词
B cell differentiation; Interleukins; T cell differentiation;
D O I
10.1016/0145-2126(90)90098-T
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many of the soluble factors controlling growth and differentiation of hematopoietic cells have recently become available as pure and recombinant proteins. This had led to a better understanding of where in the pathway of maturation and how these molecules act, as well as to the identification of specific receptors. As most readers of scientific literature have experienced, the extensive amount of data currently being published on this subject can lead to a great deal of confusion-especially for those scientists not directly involved in the field. Although new data is constantly being generated and future research will further elucidate the complexity of the role of signal molecules for hematopoietic cells, this short article is an attempt to give a simplistic overview of the present status. © 1990.
引用
收藏
页码:705 / 710
页数:6
相关论文
共 13 条
[1]  
ETTINGHAUSEN SE, 1987, BLOOD, V69, P1654
[2]  
GATELY MK, 1988, J IMMUNOL, V141, P189
[3]   HUMAN INTERLEUKIN-7 - MOLECULAR-CLONING AND GROWTH-FACTOR ACTIVITY ON HUMAN AND MURINE B-LINEAGE CELLS [J].
GOODWIN, RG ;
LUPTON, S ;
SCHMIERER, A ;
HJERRILD, KJ ;
JERZY, R ;
CLEVENGER, W ;
GILLIS, S ;
COSMAN, D ;
NAMEN, AE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (01) :302-306
[4]   THE MOLECULES CONTROLLING LYMPHOCYTES-B [J].
GORDON, J ;
GUY, GR .
IMMUNOLOGY TODAY, 1987, 8 (11) :339-344
[5]  
KASHARA T, 1983, J IMMUNOL, V130, P1784
[6]  
LONNEMANN G, 1988, LYMPHOKINE RES, V7, P75
[7]   B-CELL FACTORS ARE PLEIOTROPIC [J].
OGARRA, A ;
UMLAND, S ;
DEFRANCE, T ;
CHRISTIANSEN, J .
IMMUNOLOGY TODAY, 1988, 9 (02) :45-+
[8]   TUMOR-NECROSIS-FACTOR - POLYPEPTIDE MEDIATOR NETWORK [J].
OLD, LJ .
NATURE, 1987, 326 (6111) :330-331
[9]  
ORTALDO JR, 1984, J IMMUNOL, V133, P779
[10]   A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE [J].
ROSENBERG, SA ;
LOTZE, MT ;
MUUL, LM ;
CHANG, AE ;
AVIS, FP ;
LEITMAN, S ;
LINEHAN, WM ;
ROBERTSON, CN ;
LEE, RE ;
RUBIN, JT ;
SEIPP, CA ;
SIMPSON, CG ;
WHITE, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) :889-897